Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bone Biologics (BBLG) Return on Capital Employed (2016 - 2017)

Bone Biologics has reported Return on Capital Employed over the past 2 years, most recently at 971.69% for Q4 2017.

  • Quarterly Return on Capital Employed fell 363807.0% to 971.69% in Q4 2017 from the year-ago period, while the trailing twelve-month figure was 971.69% through Dec 2017, down 363807.0% year-over-year, with the annual reading at 1230.86% for FY2017, 417172.0% down from the prior year.
  • Return on Capital Employed was 971.69% for Q4 2017 at Bone Biologics, down from 173.66% in the prior quarter.
  • Over five years, Return on Capital Employed peaked at 2666.38% in Q4 2016 and troughed at 971.69% in Q4 2017.